Electronic Health Reporter

SEPTEMBER 17, 2020

This article is copyrighted strictly for Electronic Health Reporter. As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. Illegal copying is prohibited. Without a direct relationship with […].

Pharmaceuticals 91

Pharmaceuticals Drug Development 91

Healthcare IT Today

MARCH 15, 2024

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

Pharmaceuticals 90

Pharmaceuticals Drug Development Mental health Nursing 90

Society for Participatory Medicine

FEBRUARY 1, 2023

Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen.

BioTech 144

BioTech Drug Development Meaningful Use Pharmaceuticals 144

Insulin Nation

MARCH 24, 2019

The FDA declined to approve Zynquista a drug developed by Sanofi SA and Lexicon Pharmaceuticals intended for use with insulin in patients with Type 1 Diabetes. The generic name of the drug is sotagliflozin. See this article for details on SGLT2 Inhibitors. The decision is controversial.

Drug Development 60

Drug Development Pharmaceuticals 60

Healthcare IT Today

DECEMBER 27, 2022

According to a recent DeciBio article, Dynamyx is shown to have one of the largest partnership networks in the digital pathology space. Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A

Pharmaceuticals 59

Pharmaceuticals Drug Development Medical Technology Healthcare IT 59

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. According to a recent Deloitte article , ROI on pharma R&D has steadily declined, reaching 1.2 This decline is happening at a time when the need for efficient drug development has never been greater.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Insulin Nation

NOVEMBER 14, 2016

Within a bullet point about Obamacare is this sentence: “Reforms will also include cutting the red tape at the FDA: there are over 4,000 drugs awaiting approval, and we especially want to speed the approval of life-saving medications.”. Could this mean that there will be a streamlined pipeline for diabetes drug development?

Drug Development 75

Drug Development Pharmaceuticals 75